In a clinical trial, Wegovy demonstrated a significant effect on weight loss
Current clinical evidence for possible antidepressant effects of GLP-1R agonists Depression is often comorbid with metabolic disorders such as T2DM and obesity and many antidiabetic drugs, which often display neuroprotective and immunomodulatory effect, have demonstrated antidepressant properties in clinical trials
By enhancing metabolic efficiency, AOD9604 contributes to a balanced and energized lifestyle
Retrieved 21 December 2024 via PR Newswire
While Semaglutide can assist in managing type 2 diabetes and obesity, we also emphasize the importance of lifestyle modifications like a balanced diet and regular exercise
Emerging research has also suggested that GLP-1 medications may influence how the kidneys regulate sodium, making it even more important to maintain good hydration during hot weather, illness or periods of increased activity